白血病,骨髓性,慢性,BCR-ABL 阳性的临床试验
总计3238个结果
-
Bristol-Myers Squibb完全的
-
OHSU Knight Cancer Institute完全的
-
Masonic Cancer Center, University of Minnesota撤销
-
Medical College of WisconsinMemorial Sloan Kettering Cancer Center; Dana-Farber Cancer Institute; University of Chicago; Emory... 和其他合作者完全的
-
Tehran University of Medical Sciences完全的
-
Novartis Pharmaceuticals完全的急性淋巴细胞白血病 | 慢性粒细胞白血病日本
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)完全的
-
Mayo ClinicNational Cancer Institute (NCI)完全的
-
Merck Sharp & Dohme LLC终止白血病,淋巴细胞性,急性 | 骨髓性白血病,急性 | 白血病,淋巴细胞,急性,费城阳性 | Myelogenous Leukemia, Chronic, Aggressive Phase
-
University of Maryland, BaltimoreNational Cancer Institute (NCI)完全的
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)完全的
-
Medical College of WisconsinNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute (NHLBI); National Marrow... 和其他合作者完全的淋巴瘤 | 急性白血病 | 骨髓增生异常 | 慢性粒细胞白血病 (CML)美国
-
Novartis Pharmaceuticals完全的
-
Novartis Pharmaceuticals主动,不招人
-
University of Connecticut完全的Study Using Vaccination With Heat Shock Protein 70 (HSP70) for the Treatment of CML in Chronic Phase白血病,骨髓,慢性 | Leukemia,Myeloid,Philadelphia-Positive美国
-
Nanfang Hospital of Southern Medical University招聘中
-
Teva Branded Pharmaceutical Products R&D, Inc.终止慢性粒细胞白血病美国, 比利时, 法国, 大韩民国
-
University of British ColumbiaBristol-Myers Squibb完全的
-
University Health Network, Toronto未知
-
Bristol-Myers Squibb完全的
-
Prof. Dr. Nikolas von BubnoffNovartis终止
-
Amsterdam UMC, location VUmcMerck Sharp & Dohme LLC; Novartis; Uppsala University Hospital终止
-
Kanto CML Study GroupEpidemiological and Clinical Research Information Network完全的
-
CttqRuijin Hospital未知
-
Herbert Irving Comprehensive Cancer CenterNational Cancer Institute (NCI)完全的